{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:49:55Z","timestamp":1789436995292,"version":"build-2803163510"},"reference-count":45,"publisher":"The Royal Society","issue":"1433","license":[{"start":{"date-parts":[[2003,5,29]],"date-time":"2003-05-29T00:00:00Z","timestamp":1054166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/royalsociety.org\/journals\/ethics-policies\/data-sharing-mining\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phil. Trans. R. Soc. Lond. B"],"published-print":{"date-parts":[[2003,5,29]]},"abstract":"<jats:p>Soon after the enzymatic defects in Gaucher disease and in Niemann\u2013Pick disease were discovered, enzyme replacement or enzyme supplementation was proposed as specific treatment for patients with these and related metabolic storage disorders. While relatively straightforward in concept, successful implementation of this approach required many years of intensive effort to bring it to fruition. Procedures were eventually developed to produce sufficient quantities of the requisite enzymes for clinical trials and to target therapeutic enzymes to lipid\u2013storing cells. These achievements led to the development of effective enzyme replacement therapy for patients with Gaucher disease and for Fabry disease. These demonstrations provide strong incentive for the application of this strategy for the treatment of many human disorders of metabolism.<\/jats:p>","DOI":"10.1098\/rstb.2003.1269","type":"journal-article","created":{"date-parts":[[2003,9,9]],"date-time":"2003-09-09T11:27:32Z","timestamp":1063106852000},"page":"915-919","source":"Crossref","is-referenced-by-count":61,"title":["Enzyme replacement therapy: conception, chaos and culmination"],"prefix":"10.1098","volume":"358","author":[{"given":"Roscoe O.","family":"Brady","sequence":"first","affiliation":[{"name":"Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, Building 10, Room 3D04, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-1260, USA()"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"175","published-online":{"date-parts":[[2003,5,29]]},"reference":[{"key":"p_1","unstructured":"Aghion H. 1934 La maladie de Gaucher dans l'enfance. PhD thesis Paris University France."},{"key":"p_2","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano A.","year":"2001","journal-title":"Genet. Med."},{"key":"p_3","first-page":"99","article-title":"The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins","volume":"41","author":"Ashwell G.","year":"1974","journal-title":"Adv. Enzymol."},{"key":"p_4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.5.1913"},{"key":"p_5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105233242104"},{"key":"p_6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196608112750606"},{"key":"p_7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.47.070178.003351"},{"key":"p_8","doi-asserted-by":"crossref","unstructured":"Brady R. O. & Furbish F. S. 1982 Enzyme replacement therapy: specific targeting of exogenous enzymes to storage cells. In Membranes and transport vol. 2 (ed. A. N. Martonosi) pp. 587-592. New York: Plenum.","DOI":"10.1007\/978-1-4684-4085-0_84"},{"key":"p_9","first-page":"39","article-title":"Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue","volume":"240","author":"Brady R. O.","year":"1965","journal-title":"J. Biol. Chem."},{"key":"p_10","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(65)90743-6"},{"key":"p_11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105417"},{"key":"p_12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.55.2.366"},{"key":"p_13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196705252762101"},{"key":"p_14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(71)90249-X"},{"key":"p_15","doi-asserted-by":"publisher","DOI":"10.1126\/science.172.3979.174"},{"key":"p_16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197307052890103"},{"key":"p_17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197411072911901"},{"key":"p_18","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(76)90760-9"},{"key":"p_19","first-page":"1045","article-title":"From cytases to Iysosomes","volume":"23","author":"de Duve C.","year":"1964","journal-title":"Fed. Proc."},{"key":"p_20","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0021-9258(18)34905-6","article-title":"Enhanced macrophage uptake of synthetically glycosylated human placental b-glucocerebrosidase","volume":"257","author":"Doebber T. W.","year":"1982","journal-title":"J. Biol. Chem."},{"key":"p_21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"p_22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.8.3560"},{"key":"p_23","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(81)90474-8"},{"key":"p_24","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(70)90115-3"},{"key":"p_25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-1-199501010-00005"},{"key":"p_26","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(72)28121-6"},{"key":"p_27","first-page":"120","article-title":"Intravenous injection of purified hexosaminidase A into a patient with Tay-Sachs disease","volume":"9","author":"Johnson W. G.","year":"1973","journal-title":"Birth Defects Original Article Ser."},{"key":"p_28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101183440304"},{"key":"p_29","doi-asserted-by":"publisher","DOI":"10.1126\/science.155.3758.86"},{"key":"p_30","doi-asserted-by":"publisher","DOI":"10.1515\/bchm2.1934.229.4-6.151"},{"key":"p_31","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(69)90947-4"},{"key":"p_32","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/S0021-9258(19)43595-3","article-title":"Isolation and characterization of glucocerebrosidase from human placental tissue","volume":"248","author":"Pentchev P. G.","year":"1973","journal-title":"J. Biol. Chem."},{"key":"p_33","first-page":"73","article-title":"Replacement therapy for inherited enzyme deficiency: sustained clearance of accumulated glucocerebroside in Gaucher's disease following infusion of purified glucocerebrosidase","volume":"1","author":"Pentchev P. G.","year":"1975","journal-title":"J. Mol. Med."},{"key":"p_34","first-page":"487","article-title":"Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages","volume":"41","author":"Raz A.","year":"1981","journal-title":"Cancer Res."},{"key":"p_35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.365"},{"key":"p_36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"p_37","first-page":"222","article-title":"Efficacy and safety of prolonged enzyme replacement therapy for Fabry disease","volume":"69","author":"Schiffmann R.","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"p_38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.3.1399"},{"key":"p_39","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(62)90030-X"},{"key":"p_40","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/S0021-9258(18)51888-3","article-title":"Fabry's disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid","volume":"238","author":"Sweeley C. C.","year":"1963","journal-title":"J. Biol. Chem."},{"key":"p_41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107045"},{"key":"p_42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104175"},{"key":"p_43","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2744(68)90251-9"},{"key":"p_44","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01150-6"},{"key":"p_45","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022578424693"}],"container-title":["Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rstb.2003.1269","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rstb.2003.1269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:19:58Z","timestamp":1778620798000},"score":1,"resource":{"primary":{"URL":"http:\/\/royalsocietypublishing.org\/rstb\/article\/358\/1433\/915-919\/20213"}},"subtitle":[],"editor":[{"given":"R. A.","family":"Dwek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"T. D.","family":"Butters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"F. M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"T. M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,5,29]]},"references-count":45,"journal-issue":{"issue":"1433","published-print":{"date-parts":[[2003,5,29]]}},"alternative-id":["10.1098\/rstb.2003.1269"],"URL":"https:\/\/doi.org\/10.1098\/rstb.2003.1269","relation":{},"ISSN":["0962-8436","1471-2970"],"issn-type":[{"value":"0962-8436","type":"print"},{"value":"1471-2970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,29]]}}}